Contract Service Directory

CNS Contract Research Corp





Company Headquarters

550 University Ave
NRC Bldg. Suite 508
Charlottetown, PE C1A 4P3
Canada

Contract Service Directory

    Related Content

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
      AC Immune and WuXi Biologics Expand Strategic Partnership

      AC Immune and WuXi Biologics Expand Strategic Partnership

      Plan to accelerate AC Immune’s TDP-43 antibody into clinical development.
      Contract Pharma Staff 11.10.20

    • Drug Delivery | Drug Development | Trials & Filings
      Impel NeuroPharma Submits NDA for INP104 in Acute Migraine

      Impel NeuroPharma Submits NDA for INP104 in Acute Migraine

      Leverages the company’s Precision Olfactory Delivery technology
      11.09.20

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News | R&D
      Sai Life Sciences to Expand Biology Capabilities

      Sai Life Sciences to Expand Biology Capabilities

      Begins construction of new 75,000 sq. ft. facility in Hyderabad; adding 170 biologists to team.
      Contract Pharma Staff 10.28.20


    • Breaking News | Clinical Trials
      CNS Pharmaceuticals Completes U.S. Manufacturing of Berubicin

      CNS Pharmaceuticals Completes U.S. Manufacturing of Berubicin

      Phase 2 trial will commence during the first quarter of 2021.
      Contract Pharma Staff 10.20.20

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
      Dyno, Roche Ink Gene Therapy Deal Worth up to $1.8B

      Dyno, Roche Ink Gene Therapy Deal Worth up to $1.8B

      Collaboration combines Dyno’s AI-powered AAV vector capabilities with Roche and Spark Therapeutics’ gene therapy capabilities.
      Contract Pharma Staff 10.14.20

    • APIs | Breaking News | Industry News
      NCK A/S Receives CoA for Berubicin API

      NCK A/S Receives CoA for Berubicin API

      CNS has a contract with NCK A/S for the large-scale production of Berubicin, its lead drug candidate for the treatment of glioma brain tumors.
      Contract Pharma Staff 10.01.20


    • Breaking News | cGMP Manufacture | Fill/Finish | Industry News
      LSNE, Selecta Biosciences Form Mfg. Pact

      LSNE, Selecta Biosciences Form Mfg. Pact

      LSNE to provide drug substance manufacturing and fill/finish services
      05.24.17

    • Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Industry News
      Selexis SA and OSE Immunotherapeutics Enter Pact

      Selexis SA and OSE Immunotherapeutics Enter Pact

      Sign agreement for the development of OSE's interleukin receptor 7 antagonist
      05.24.17

    • Breaking News | Collaborations & Alliances | Drug Development | Industry News | Preclinical Outsourcing | R&D
      Nektar and Takeda in Research Collaboration

      Nektar and Takeda in Research Collaboration

      Will explore combination cancer therapies
      05.22.17


    • Clinical Trials | CRO News

      PSI CRO to Open New Office in Durham

      Aims to offer an ideal collaborative setting for both clients and staff in RTP
      05.10.16

    • Breaking News | Drug Development | Formulation Development | Industry News | Methods Development

      Sanofi Licenses Ligand’s Captisol Technology

      Will use Captisol in the development and commercialization of cancer therapy SAR-125844
      07.30.15

    • Breaking News | Clinical Trials | Drug Development | Financial Reports

      Financial Report: INC Research

      Revenues up 14% in the quarter
      07.30.15


    • Breaking News | Clinical Trials | Drug Development | Industry News | R&D

      Novartis Acquires Spinifex Pharmaceuticals

      Expands neuroscience portfolio with novel angiotensin II type 2 receptor antagonist for the treatment of chronic pain
      07.01.15

    • Breaking News | Financial Reports

      Financial Report: INC Research 1Q

      Service revenues up 15%
      04.28.15